CN Stock MarketDetailed Quotes

600351 Yabao Pharmaceutical Group

Watchlist
  • 6.00
  • -0.08-1.32%
Market Closed Feb 28 15:00 CST
4.32BMarket Cap19.54P/E (TTM)

Yabao Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Yabao Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Apr 24, 20192019/Q1821.494M / 753.000M--
DatePeriodRevenue/EstimateEarnings Call
Apr 24, 20192019/Q1821.494M / 753.000M--

Yabao Pharmaceutical Group Earnings Reports

  • Yabao Pharmaceutical Group Co., Ltd. Report for the Third Quarter of 2024 (Revised Edition)

    Oct 25, 2024 12:00 ET

  • Yabao Pharmaceutical Group Co., Ltd. 2024 Third Quarter Report Correction Notice

    Oct 25, 2024 12:00 ET

  • Yabao Pharmaceutical Group Co., Ltd. Report for the Third Quarter of 2024

    Oct 24, 2024 12:00 ET

  • Yabao Pharmaceutical Group Co., Ltd. 2024 Semi-annual Report

    Aug 14, 2024 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    LINTEX
    920106
    91.00 +30.00%
    LINGOOD
    833284
    27.92 +29.98%
    NTGEC
    870436
    24.93 +29.98%
    CG MED EQUIP.
    838810
    19.82 +29.97%
    Jiayu Holding
    300117
    1.00 +20.48%

    See the daily top gainer.

    Investment Theme Traditional Chinese Medicine Concept
    Traditional Chinese Medicine Concept
    Intraday-1.29%
    Innovative Drugs
    Innovative Drugs
    Intraday-1.66%
    ShangHai Stock Connect
    ShangHai Stock Connect
    Intraday-1.71%